HomeNDC LookupRxCUI directory › RxCUI 807834

24 HR levetiracetam 500 MG Extended Release Oral Tablet [Keppra] — RxCUI 807834

RxNorm drug concept · Semantic branded drug
RxCUI 807834 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI807834
Official name24 HR levetiracetam 500 MG Extended Release Oral Tablet [Keppra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Keppra 500 MG Extended Release Oral Tablet; KEPPRA XR 500 MG 24HR Extended Release Oral Tablet, Once-Daily; Keppra XR 500 MG 24 HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)7,028 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levetiracetam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Levetiracetam is an anti-seizure medicine. Depending on the product and your age, it can be used to treat partial-onset seizures (seizures starting in one part of the brain), myocl...
  • What is levetiracetam actually used for?
  • It can, especially when you first start taking it. Drowsiness, fatigue, and dizziness are among the most common side effects and tend to be most noticeable in the first few weeks....
  • Will levetiracetam make me feel tired or foggy?
📖 Read our full Levetiracetam guide →

🕸️ Concept Web — How 24 HR levetiracetam 500 MG Extended Release Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR levetiracetam 500 MG Extended Release Oral Tablet [Keppra] RxCUI 807834

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levetiracetam 114477
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Keppra 261547
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levetiracetam Extended Release Oral Tablet 807831
    • Levetiracetam Oral Product 1163451
    • Levetiracetam Pill 1163452
    • Levetiracetam Extended Release Oral Tablet [Keppra] 807833
    • Keppra Oral Product 1170054
    • Keppra Pill 1170055
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Levetiracetam 500 MG [Keppra] SBDC · 574556
  • Levetiracetam Extended Release Oral Tablet [Keppra] SBDF · 807833
  • Keppra Oral Product SBDG · 1170054
  • Keppra Pill SBDG · 1170055
  • Keppra BN · 261547

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 807834 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50474-0598-66 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... Keppra XR UCB, Inc. 2008-09-24
50474-0599-66 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... Keppra XR UCB, Inc. 2009-04-01
Observed labelers: UCB, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.